Wikipedia -WSS

Wikipedia

author：leisure time 2025-09-08 19:22:27 - browse：672

This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. — Illustration: Alex Hogan/STAT; Photo: Eisai via AP

Medicare has officially expanded its coverage policy for brain scans that detect a brain plaque associated with Alzheimer’s disease, the agency announced on Friday.

Amyloid PET scans are important tools to help determine whether patients with mild cognitive impairment are good candidates for new Alzheimer’s drugs, including Eisai and Biogen’s drug Leqembi, which means there will likely be an increase in demand for the scans as uptake increases.

Previously, Medicare limited coverage for the drug to patients enrolled in clinical studies, and only covered one scan in a patient’s lifetime. The new coverage policy removes those restrictions and delegates decisions about how many scans to cover to regional Medicare administrators.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Trump demands the U.S. pay no more for drugs than other countries … again
Next article： Scientists find bacteria from stomach of ancient iceman

WSS

Rock icon Freddie Mercury pre

Cassava reveals details — and problems — with Alzheimer's study

Parkland mass shooting to be reenacted for lawsuit

Medical schools are missing the mark on artificial intelligence

Medical schools are missing the mark on artificial intelligence

Biden's order seeks to regulate AI risk without stifling innovation

explore

Wikipedia

entertainment

Dobbs anniversary: the lost opportunity of abortion as health care

Russian court extends detention of American musician

Malaria cases in Florida and Texas: Here’s what you need to know

Medtronic CEO on promising devices for diabetes, hypertension

ChatGPT in medicine: STAT answers readers' burning questions

Traditional Chinese medicine benefits explored in new JAMA study

Dobbs anniversary: the lost opportunity of abortion as health care

Cassava reveals details — and problems — with Alzheimer's study

Medicare proposal to cover medical devices draws a mixed reaction

Does Medicare's free annual wellness visit do any good?

hotspot

Does Medicare's free annual wellness visit do any good?

Physician subsidies by hospitals soar in wake of No Surprises Act

Judge in Trump's Jan. 6 case gives attorneys 2 weeks to propose trial date

Pharma needs to include young adults in clinical research

Prosecutors seek bail revocation for FTX founder Sam Bankman

FDA has safety concerns on CRISPR

knowledge

leisure time

knowledge

knowledge